|
| Press Releases |
|
 |
|
| Tuesday, May 30, 2023 |
|
|
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China |
| On May 30, China Medical System Holdings Limited ("CMS" or the "Group") announced that on 26 May 2023, the New Drug Application (NDA) of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China (NMPA). ILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. more info >> |
|
|
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China |
| On May 30, China Medical System Holdings Limited ("CMS" or the "Group") announced that on 26 May 2023, the New Drug Application (NDA) of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China (NMPA). ILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. more info >> |
|
| Monday, December 19, 2022 |
|
|
Gelonghui Reports CMS' Successful Phase III Study of Methylthioninium Chloride Enteric-coated Sustained-release Tablets |
| Gelonghui released a Press Release on "China Medical System Holdings Limited's innovative product Methylthioninium Chloride Enteric-coated Sustained-release Tablets ('the Product') has obtained positive results for its Phase III clinical trial in China." more info >> |
|
| Friday, November 18, 2022 |
|
|
China Medical System (867.HK) S&P Global CSA Score Achieved Significant Improvement, Leading the Industry Globally |
| Recently, the S&P Global Corporate Sustainability Assessment (S&P Global CSA) released the 2022 Environmental, Social and Governance (ESG) scores for China Medical System Holdings Limited ("CMS" or the "Group"). CMS achieved a significant improvement with a score of 53 in 2022 from 36 in 2021, surpassing 92% of the global peers and being significantly ahead of the industry average. more info >> |
|
| Tuesday, September 6, 2022 |
|
|
CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy |
| more info >> |
|
| Friday, August 26, 2022 |
|
|
CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy |
| more info >> |
|
| Monday, April 26, 2021 |
|
|
Starting its Industrial Investment in Biotech Companies, China Medical System (0867.HK) has Accelerated its Flywheel of Innovation |
| China Medical System Holdings Limited (0867.HK) ("CMS" or the "Company") has been active in the market this year. more info >> |
|
|
泰諾麥博宣佈完成4.5億元人民幣A輪融資 |
| 近日，珠海泰諾麥博生物技術有限公司（Trinomab Biotech Co., Ltd. 簡稱“泰諾麥博”或“Trinomab”）宣佈完成4.5億元人民幣的A輪融資，此次融資由高瓴創投領投，康哲藥業、藥明生物產業基金、無錫國聯等共同參與完成。 more info >> |
|
|
泰诺麦博宣布完成4.5亿元人民币A轮融资 |
| 近日，珠海泰诺麦博生物技术有限公司（Trinomab Biotech Co., Ltd. 简称“泰诺麦博”或“Trinomab”）宣布完成4.5亿元人民币的A轮融资，此次融资由高瓴创投领投，康哲药业、药明生物产业基金、无锡国联等共同参与完成。 more info >> |
|
| Monday, April 5, 2021 |
|
|
China Medical System (0867.HK) Accelerating Development and Stepping to New Heights, Driven by Innovation |
| As the earning season approaches, once again listed pharmaceutical companies are attracting the attention of the public. Recently, China Medical System Holdings Limited ("CMS" or the "Company") has released its annual results, with both revenue and profit higher than market expectations. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Masverse Unveils Groundbreaking Blockchain Platform
Apr 27, 2024 02:40 HKT/SGT
|
|
|
Spritzer Scores Big with 'Meet the Red Legends' Event for Football Fans
Apr 26, 2024 23:00 HKT/SGT
|
|
|
Announcing Mad About Marketing - A New Member of the Digital Sukoon Private Limited Family
Apr 26, 2024 22:25 HKT/SGT
|
|
|
FinTech Funding Continues to Surge as Second Edition of Dubai FinTech Summit Commences
Apr 26, 2024 21:10 HKT/SGT
|
|
|
汇聚科技有限公司公布截至二零二三年十二月三十一日止末期业绩
Apr 26, 2024 18:53 HKT/SGT
|
|
|
匯聚科技有限公司公佈截至二零二三年十二月三十一日止末期業績
Apr 26, 2024 18:43 HKT/SGT
|
|
|
UK advertising reports GBP36.6bn spend in 2023
Apr 26, 2024 18:30: JST
|
|
|
TIME Interconnect Technology Limited Announces Final Results For The Nine Months Ended 31 December 2023
Apr 26, 2024 18:26 HKT/SGT
|
|
|
UK advertising reports GBP36.6bn spend in 2023
Apr 26, 2024 17:30 HKT/SGT
|
|
|
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine
Apr 26, 2024 15:36 HKT/SGT
|
|
|
可持续发展三大支柱引领 海通恒信ESG必答卷高分亮相
Apr 26, 2024 15:28 HKT/SGT
|
|
|
可持續發展三大支柱引領 海通恆信ESG必答卷高分亮相
Apr 26, 2024 15:25 HKT/SGT
|
|
|
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project
Apr 26, 2024 14:34: JST
|
|
|
スパークス・グループによる「宇宙フロンティア2号ファンド」の設立について
Apr 26, 2024 14:00: JST
|
|
|
中滙集團公佈2024財年中期業績
Apr 26, 2024 13:51 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
